Hongene Biotech Corporation’s Post

"Happy International Day of Argenia! Today, we celebrate the rich culture, history, and contributions of Argenia to the world. From its stunning landscapes to its vibrant traditions, Argenia captivates hearts globally. Let's honor this special day by embracing the spirit of Argenia and spreading joy and unity wherever we go. #InternationalDayofArgenia #CelebrateCulture #DigitalPublication #AcademicJournal #OpenAccessJournal #PeerReviewed #ResearchJournal #SocialScienceJournal #MedicalJournal #TechJournal #EducationJournal #HealthJournal #ArtJournal #Literature

In our quest to bring projects "From Lab to Success", we try every day to support talented #LifeScience teams making an #impact on the development of new therapies, and we provide researchers in #Pharma & #Biotech with valuable tools to bring their therapies from the lab to the patient. A key part of this job is working with partners developing new disruptive #technologies and helping them reaching market scale. We are honored and excited to start this journey with Altis Biosystems, and can't wait to change the way #gut research, #toxicity and #absorption testing is performed. As Altis' team says "Go with your gut!" #innovation #preclinical #research #teamwork

"Happy International Day of Argenia! Today, we celebrate the rich culture, history, and contributions of Argenia to the world. From its stunning landscapes to its vibrant traditions, Argenia captivates hearts globally. Let's honor this special day by embracing the spirit of Argenia and spreading joy and unity wherever we go. #InternationalDayofArgenia #CelebrateCulture #DigitalPublication #AcademicJournal #OpenAccessJournal #PeerReviewed #ResearchJournal #SocialScienceJournal #MedicalJournal #TechJournal #EducationJournal #HealthJournal #ArtJournal #Literatur

"Happy International Day of Argenia! Today, we celebrate the rich culture, history, and contributions of Argenia to the world. From its stunning landscapes to its vibrant traditions, Argenia captivates hearts globally. Let's honor this special day by embracing the spirit of Argenia and spreading joy and unity wherever we go. #InternationalDayofArgenia #CelebrateCulture #DigitalPublication #AcademicJournal #OpenAccessJournal #PeerReviewed #ResearchJournal #SocialScienceJournal #MedicalJournal #TechJournal #EducationJournal #HealthJournal #ArtJournal #Literatur

𝗪𝗿𝗮𝗽𝗽𝗶𝗻𝗴 𝗨𝗽 𝗕𝗜𝗢-𝗘𝘂𝗿𝗼𝗽𝗲 𝗦𝗽𝗿𝗶𝗻𝗴 𝟮𝟬𝟮𝟰 𝗶𝗻 𝗕𝗮𝗿𝗰𝗲𝗹𝗼𝗻𝗮 💼    As we bid farewell to BIO-Europe Spring 2024, let's take a moment to reflect on the lively atmosphere and collaborative spirit that filled the event's halls.    ✨ Facts & Figures ✨    🤝 ~120,000 meeting requests  🤝 ~20,000 meetings  🏢 1,947 companies represented  👥 3,452 delegates attended  💌 MONIPOL prepared ~280 meeting requests and had 25 meetings    These numbers speak volumes about the energy and collaboration present at the event. We were fortunate to connect with many companies interested in exploring our services: throughout the event, we made it a priority to prepare thoroughly and understand our potential clients' needs. This emphasis on research and client-centricity beforehand ensured that meetings were not only productive but also truly beneficial for everyone involved 🤝    𝐇𝐚𝐯𝐞 𝐲𝐨𝐮 𝐦𝐢𝐬𝐬𝐞𝐝 𝐭𝐡𝐞 𝐜𝐡𝐚𝐧𝐜𝐞 𝐭𝐨 𝐜𝐨𝐧𝐧𝐞𝐜𝐭 𝐰𝐢𝐭𝐡 𝐮𝐬 𝐚𝐭 𝐭𝐡𝐞 𝐞𝐯𝐞𝐧𝐭? Don't worry! Contact us for follow-ups and learn more about how we can support your trials. Let's continue the conversation and explore exciting opportunities at the Virtual Partnering Event, held on 26-27 March 📅     A big thank you to everyone who made BIO-Europe Spring 2024 such a success. We are looking forward to connecting further and supporting innovative biotech pioneers.    Another big thanks to EBD Group for providing a platform to connect the global BioPharma community. We are pleased to have played a part in fostering this vibrant atmosphere.      #BIOEuropeSpring #Biotech #CRO #clinicaltrials #clinicaldevelopment 

Why is ArgusEye developing the Auga platform?💡 CEO Dr. Erik Martinsson answers in the video below! Learn more about the first product in the Auga platform AugaOne here: https://lnkd.in/dSvAwxYN #ArgusEye #AugaPlatform #BiopharmaInnovation #RealTimeData #DrugDevelopment #Innovation

@Catailyst, Inc. Trending Topics: Sangamo Therapeutics, Inc. Therapeutics Announces Alignment With FDA on Accelerated Approval Pathway for ST-920 in #Fabry Disease With BLA Submission Expected in 2025 https://lnkd.in/d-HxtncX FDA confirms that estimated glomerular filtration rate (eGFR) slope data at one year across all Phase 1/2 patients can serve as primary basis for approval under Accelerated Approval pathway #Timeline Data supporting Accelerated Approval pathway available in first half of 2025 BLA submission expected in the second half of 2025. #Healthcare #FDA #Biotechnology #Fabry

#France's #Sanofi could become the latest #bigpharma company to exit the #consumerhealthcare #business. It is in talks to sell a 50% #controllingstake in its #consumer #health unit #Opella, which employs over 11,000 people and has operations in 100 countries. Sanofi’s move follows similar divestments by other #pharmaceutical #companies such as #GSK and #JNJ. Consumer healthcare will remain a key segment, given strong #demand for #everydayproducts like #vitamins, #skincare and #cosmetics. Then why are these #pharma companies exiting consumer health? Will others follow suit? Read my take here: https://lnkd.in/gRsTRatW

Accelerating toward profitability - Oncopeptides publishes the 2023 Annual Report “2023 was a year when we set ourselves up for success in Europe. We built the foundation in Germany where we now have a full team in place and have secured a price that reflects our scientific innovation. This was a critical achievement to ensure a reference price point for the rest of Europe where we during the year worked intensively to progress market access,” says Sofia Heigis ♦️, CEO of Oncopeptides. “Commercializing a new drug doesn’t happen overnight, but I am fully convinced that we are on the right track and that we slowly but surely have started to gain speed.” The Annual Report for 2023 is available in Swedish at Oncopeptides’ web site under financial reports, where an unofficial translation in English also can be found: https://lnkd.in/dmSmsEDu

Meet Paul Eastwood, our Export Sales Manager, who's been with Exol for an impressive 29 years! 👏 As we celebrate our 40th anniversary this year, we sat down with Paul to discuss Exol's evolution over the past four decades and his insights on the future of the industry. Click here to hear what he had to say 👉 #ExolLubricants #ExolTurns40 #MeetTheTeam #IndustryInsights